Evidence map›Paper›PMID 32666128›Full record

ArticleArchives of gynecology and obstetrics2020

Breast cancer in women younger than 35 years old.

Dimitrios Zouzoulas, Dimitrios Tsolakidis, Georgios Gitas, Menelaos Zafrakas, Dimitrios G Goulis, George Douganiotis, Georgios Sympilidis, Grigorios Grimbizis

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Dimitrios ZouzoulasSurgical-Oncologic Breast Cancer Department, "Theagenio" Anticancer Hospital, Thessaloniki, Greece. dzouzoulas@hotmail.gr.ORCID http://orcid.org/0000-0003-2518-5657
Dimitrios Tsolakidis1st Department of Obstetrics - Gynecology Clinic, AUTh, "Papageorgiou" Hospital, Thessaloniki, Greece.
Georgios GitasDepartment of Gynaecology and Obstetrics, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany.
Menelaos ZafrakasATEITh, Thessaloniki, Greece.
Dimitrios G Goulis1st Department of Obstetrics - Gynecology Clinic, AUTh, "Papageorgiou" Hospital, Thessaloniki, Greece.
George Douganiotis3rd Department of Clinical Oncology, "Thegeneio" Anticancer Hospital, Thessaloniki, Greece.
Georgios SympilidisSurgical-Oncologic Breast Cancer Department, "Theagenio" Anticancer Hospital, Thessaloniki, Greece.
Grigorios Grimbizis1st Department of Obstetrics - Gynecology Clinic, AUTh, "Papageorgiou" Hospital, Thessaloniki, Greece.
Papageorgiou General Hospital · GRTheageneio General Hospital · GRUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWomen ≤ 35 years old with breast cancer constitute a special group. Considering the impact of the disease and its prognosis, these patients face some specific problems that are not present in older women. What are the prognostic features of the survival rate in very young women with breast cancer?

methodsRetrospective analysis of very young women with breast cancer from the Surgical-Oncologic Breast Cancer Department at "Theagenio" Anticancer Hospital, 2003-2016. Patient and tumor characteristics, treatment options and follow-up information were collected. Univariate-multivariate analyses were conducted and survival rates were calculated.

resultsThe median age was 34 years old. 53 patients (41%) had T1, 36 (28%) had T2, 7 (5.4%) had T3 and 33 (25.6%) had T4 stage tumors. Most women, 114 (88.4%), had ductal carcinoma in their histology. Furthermore, positive axillary lymph nodes were present in 62 women (48%). In the immunochemistry report, 91 patients (70.5%) were hormone receptor positive, HER2 was overexpressed in 32 patients (24.8%) and 27 patients presented with triple-negative subtype. Out of 65 patients tested for Ki-67, 51 (78.5%), had a high expression (cut-off value of 20%). After adjusting for all possible factors, the risk of recurrence and death was six times higher in the positive lymph node group, (p < 0.001). The median disease-free and overall survival was 133 and > 173 months, respectively.

conclusionBreast cancer in very young women appears with large size and high-grade tumors, high incidence of infiltrated axillary lymph nodes, high Ki-67 expression and intrinsic subtypes with poor prognosis. As a result, these women need to be treated by a multidisciplinary team.

Indexed as

AdultBreast NeoplasmsFemaleHumansPrognosisRetrospective StudiesSurvival RateYoung AdultBreast cancerPrognostic featuresSurvival ratesVery young women

Identifiers

PMID32666128
OpenAlexW3043149092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.